Personal Genomics for Preventive Cardiology
A Pilot Randomized Trial of Personal Genomics for Preventive Cardiology
1 other identifier
interventional
100
1 country
1
Brief Summary
The purpose of this study is to see if providing information to a person on their inherited (genetic) risk of cardiovascular disease (CVD) helps to motivate that person to change their diet, lifestyle or medication regimen to alter their risk.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable coronary-artery-disease
Started Aug 2011
Longer than P75 for not_applicable coronary-artery-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 28, 2011
CompletedFirst Posted
Study publicly available on registry
August 1, 2011
CompletedStudy Start
First participant enrolled
August 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2017
CompletedOctober 5, 2017
October 1, 2017
5.2 years
July 28, 2011
October 3, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
change in LDL cholesterol
6 mo
Secondary Outcomes (5)
change in weight
6 mo
change in exercise
6 mo
medication compliance
6 mo
non-HDL cholesterol
6 mo
blood pressure
6 mo
Study Arms (2)
standard of care plus genetic information
OTHERusual standard of care without genetic information
NO INTERVENTIONInterventions
genetic risk score based on coronary artery disease genetic risk variants (SNPs)
Eligibility Criteria
You may qualify if:
- Adults age \> 18
- Patient seeking cardiovascular risk evaluation
- At intermediate (6-20%) or high risk (\> 20%) over 10 years of CAD as defined by Framingham 10 year risk score AND/OR at \> 20% risk of CAD over 30 years using the Framingham 30 year risk calculator
- The genetic risk factors have been evaluated predominantly in white/European subjects. However, there is considerable overlap in the genetic architecture of South Asians and Hispanic/Latino populations. Therefore, we will limit our initial studies to these three race/ethnicity groups.
You may not qualify if:
- History of myocardial infarction, angina, stroke, peripheral arterial disease, PCI, or CABG
- Already on lipid lowering therapy
- Anticipated survival \<1 year (e.g. metastatic cancer)
- Serious conditions that would limit ability to adhere to recommendations (inability to take statins, exercise)
- Already had genetic testing
- Concurrent enrollment in another clinical trial
- Pregnant or breastfeeding
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Stanford Medical Center
Stanford, California, 94305, United States
Related Publications (2)
Knowles JW, Assimes TL, Kiernan M, Pavlovic A, Goldstein BA, Yank V, McConnell MV, Absher D, Bustamante C, Ashley EA, Ioannidis JP. Randomized trial of personal genomics for preventive cardiology: design and challenges. Circ Cardiovasc Genet. 2012 Jun;5(3):368-76. doi: 10.1161/CIRCGENETICS.112.962746. No abstract available.
PMID: 22715281BACKGROUNDKnowles JW, Zarafshar S, Pavlovic A, Goldstein BA, Tsai S, Li J, McConnell MV, Absher D, Ashley EA, Kiernan M, Ioannidis JPA, Assimes TL. Impact of a Genetic Risk Score for Coronary Artery Disease on Reducing Cardiovascular Risk: A Pilot Randomized Controlled Study. Front Cardiovasc Med. 2017 Aug 14;4:53. doi: 10.3389/fcvm.2017.00053. eCollection 2017.
PMID: 28856136RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Joshua W. Knowles, MD-PhD
Stanford University
- PRINCIPAL INVESTIGATOR
Themistocles L Assimes, MD-PhD
Stanford University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 28, 2011
First Posted
August 1, 2011
Study Start
August 1, 2011
Primary Completion
October 1, 2016
Study Completion
August 1, 2017
Last Updated
October 5, 2017
Record last verified: 2017-10